Improvement of MASLD and MASH by suppression of hepatic N-acetyltransferase 10

• Main Authors: Yanying Yang (Author), Jie Lu (Author), Yuejun Liu (Author), Ni Zhang (Author), Yunchen Luo (Author), Mingyue Ma (Author), Zhixia Dong (Author), Shuo Zhang (Author), Ming-Hua Zheng (Author), Cheng-Chao Ruan (Author), Xinjian Wan (Author), Cheng Hu (Author), Yan Lu (Author), Xiaojing Ma (Author), Bing Zhou (Author)
• Format: Book
• Published: Elsevier, 2024-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) are characterized by excessive triglyceride accumulation in the liver. However, due to an incomplete understanding of its pathogenesis, more efforts are needed to i...